MODELING MONOCYTE-DERIVED DENDRITIC CELLS AS A THERAPEUTIC VACCINE AGAINST HIV

DOI10.1142/S0218339018500262zbMath1415.92116OpenAlexW2907108353WikidataQ128671929 ScholiaQ128671929MaRDI QIDQ4967054

Shubhankar Saha, Priti Kumar Roy, Robert J. Smith?

Publication date: 2 July 2019

Published in: Journal of Biological Systems (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1142/s0218339018500262

zbMATH Keywords

HIVmathematical modelvaccinationmonocyte-derived dendritic cells

Mathematics Subject Classification ID

Global stability of solutions to ordinary differential equations (34D23) Medical epidemiology (92C60)

Related Items (4)

Critical observation of WHO recommended multidrug therapy on the disease leprosy through mathematical study ⋮ A statistical inference in an epidemic model with combinational drug treatment: HIV as a case study ⋮ How can HPV-induced cervical cancer be controlled by a combination of drug therapy? A mathematical study ⋮ The influence of vaccination on the control of JE with a standard incidence rate of mosquitoes, pigs and humans

Cites Work

• Global properties of basic virus dynamics models
• Drug resistance in an immunological model of HIV-1 infection with impulsive drug effects
• Can the viral reservoir of latently infected \(CD4^{+}\) T cells be eradicated with antiretroviral HIV drugs?
• A class age-structured HIV/AIDS model with impulsive drug-treatment strategy
• Immunodominance analysis through interactions of CD8\(^+\) T cells and DCs in lymph nodes
• Mathematical modelling of enfuvirtide and protease inhibitors as combination therapy for HIV
• Global behaviour of an age-infection-structured HIV model with impulsive drug-treatment strategy
• Dynamics of HIV infection of CD4\(^ +\) T cells
• Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission
• Optimal drug treatment regimens for HIV depend on adherence
• Resistance to protease inhibitors in a model of HIV-1 infection with impulsive drug effects
• The effect of vaccination to dendritic cell and immune cell interaction in HIV disease progression
• Anti-viral drug treatment along with immune activator IL-2: a control-based mathematical approach for HIV infection

This page was built for publication: MODELING MONOCYTE-DERIVED DENDRITIC CELLS AS A THERAPEUTIC VACCINE AGAINST HIV